Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience
Health Affairs · 2024
DOI: 10.1377/hlthaff.2024.00032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Omeid Heidari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Omeid Heidari (oheidar1@uw.edu), University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Needle-Exchange Programs, COVID-19, COVID-19 Vaccines, Substance Abuse, Intravenous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
People who inject drugs face many challenges that contribute to poor health outcomes, including drug overdose, HIV, and hepatitis C infections. These conditions require high-quality prevention and treatment services. Syringe services programs are evidence-based harm reduction programs, and they have established track records with people who inject drugs, earning them deep trust within this population. In Baltimore, Maryland, although many syringe support services were limited during the COVID-19 pandemic, the health department's syringe services programs remained operational, allowing for the continuation of harm reduction services, including naloxone distribution. This evaluation describes a collaborative effort to colocate infectious disease testing and COVID-19 vaccination with a syringe services program. Our evaluation demonstrated that colocation of important services with trusted community partners can facilitate engagement and is essential for service uptake. Maintaining adequate and consistent funding for these services is central to program success. Colocation of other services within syringe services programs, such as medications for opioid use disorder, wound care, and infectious disease treatment, would further expand health care access for people who inject drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Omeid Heidari (oheidar1@uw.edu), University of Washington, Seattle, Washington.
- Diane Meyer, Johns Hopkins University, Baltimore, Maryland.
- Kelly Lowensen, Johns Hopkins University.
- Amita Patil, Johns Hopkins University.
- Katie J. O'Conor, Johns Hopkins University.
- Jessica LaRicci, Johns Hopkins University.
Förderung
- NCATS NIH HHS
Zitieren
APA
Heidari, O., Meyer, D., Lowensen, K., Patil, A., O'Conor, K. J., LaRicci, J., Hunt, D., Bocek, A. P., Cargill, V., & Farley, J. E. (2024). Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00032
Vancouver
Heidari O, Meyer D, Lowensen K, Patil A, O'Conor KJ, LaRicci J, et al. Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience. Health Affairs. 2024. doi:10.1377/hlthaff.2024.00032
BibTeX
@article{Heidari2024,
author = {Heidari, Omeid and Meyer, Diane and Lowensen, Kelly and Patil, Amita and O'Conor, Katie J and LaRicci, Jessica and Hunt, Derrick and Bocek, Adam P and Cargill, Victoria and Farley, Jason E},
title = {Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience},
journal = {Health Affairs},
year = {2024},
doi = {10.1377/hlthaff.2024.00032}
}
EUVIMED